Kedokteran & Kesehatan editorial
Open AccessOA2023
Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
This review synthesizes contemporary data on the epidemiology, clinical characteristics, cause-specific outcomes, costs, and pharmacotherapy of heart failure with preserved ejection fraction (HFpEF), highlighting its growing burden and distinct profile compared to HFrEF.
Chris J. Kapelios; B. Shahim; L. Lund; G. Savareseยท Cardiac failure reviewยท 2023ยท DOI 10.15420/cfr.2023.03
The core problem
Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less attention than its main counterpart, HF with reduced ejection fraction (HFrEF). The incidence and prevalence of HFpEF show geographic variation and are increasing over time, soon expected to surpass those of HFrEF. Morbidity and mortality rates of HFpEF are considerable, albeit lower than those of HFrEF. This review focuses on the burden of HFpEF, providing contemporary data on epidemiology, clinical characteristics and comorbidities, cause-specific outcomes, costs and pharmacotherapy.
Innovation
The authors conducted a narrative review of the literature, synthesizing contemporary data on the epidemiology, clinical characteristics, cause-specific outcomes, costs, and pharmacotherapy of HFpEF. The review draws on published studies and registries to provide a comprehensive overview of the burden of HFpEF.
Introduction
Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less attention than its main counterpart, HF with reduced ejection fraction (HFrEF). The incidence and prevalence of HFpEF show geographic variation and are increasing over time, soon expected to surpass those of HFrEF. Morbidity and mortality rates of HFpEF are considerable, albeit lower than those of HFrEF. This review focuses on the burden of HFpEF, providing contemporary data on epidemiology, clinical characteristics and comorbidities, cause-specific outcomes, costs and pharmacotherapy.
Why it matters
The authors discuss the implications of the growing burden of HFpEF, emphasizing the need for increased attention to this condition. They highlight the distinct clinical profile and outcomes of HFpEF compared to HFrEF, and the importance of tailored management strategies. The review underscores the considerable morbidity, mortality, and costs associated with HFpEF, and the need for effective pharmacotherapy.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ